phase readout
saveNCT05958121: IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors
RECRUITINGupdated 2h ago
community read0 votes
Sponsor: Immatics Biotechnologies GmbH. Phase: PHASE1. Conditions: Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer
view source ↗
comments(0)
5-min edit window · permanent after that